scholarly article | Q13442814 |
P50 | author | Duc J Vugia | Q94703851 |
Shelley M Zansky | Q106342535 | ||
Patricia M Griffin | Q124220349 | ||
P2093 | author name string | L Hannah Gould | |
Kirk Smith | |||
Sharon Hurd | |||
Amanda Palmer | |||
Timothy F Jones | |||
Beletshachew Shiferaw | |||
Linda Demma | |||
Suzanne Segler | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
P1104 | number of pages | 6 | |
P304 | page(s) | 1480-1485 | |
P577 | publication date | 2009-11-01 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. | |
P478 | volume | 49 |
Q36258468 | A Couple's Colitis. |
Q90100162 | A Multistate Outbreak of E Coli O157:H7 Infections Linked to Soy Nut Butter |
Q33441910 | A rare case of thrombotic microangiopathy triggered by acute pancreatitis |
Q39045924 | An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years |
Q47186634 | An outbreak of Escherichia coli O157:H7 infections following a dairy education school field trip in Washington state, 2015. |
Q99569117 | Association between Shiga Toxin-Producing Escherichia coli O157:H7 stx Gene Subtype and Disease Severity, England, 2009-2019 |
Q33409684 | Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011. |
Q48361089 | Blood urea nitrogen to serum creatinine ratio is an accurate predictor of outcome in diarrhea-associated hemolytic uremic syndrome, a preliminary study. |
Q93354017 | Case definitions of hemolytic uremic syndrome following Escherichia coli O157:H7 infection vary in validity |
Q33398432 | Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center |
Q33412570 | Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae |
Q39121720 | Clinical Evaluation and Cost Analysis of Great Basin Shiga Toxin Direct Molecular Assay for Detection of Shiga Toxin-Producing Escherichia coli in Diarrheal Stool Specimens. |
Q40101247 | Colonisation of Meat by Escherichia coli O157:H7: Investigating Bacterial Tropism with Respect to the Different Types of Skeletal Muscles, Subtypes of Myofibres, and Postmortem Time. |
Q64094847 | Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics |
Q33396577 | Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009. |
Q99636418 | Determining the long-term health burden and risk of sequelae for 14 foodborne infections in British Columbia, Canada: protocol for a retrospective population-based cohort study |
Q33429632 | Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012. |
Q33405827 | Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome |
Q90383176 | Draft Genome Sequences of Seven Strains of Shiga Toxin-Producing Escherichia coli O111 with Variation in Their Sensitivity to Novobiocin |
Q42263143 | Duration of shedding of Verocytotoxin-producing Escherichia coli in children and risk of transmission in childcare facilities in England. |
Q51783073 | Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study. |
Q34889826 | Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue |
Q39093646 | Emerging Public Health Challenges of Shiga Toxin-Producing Escherichia coli Related to Changes in the Pathogen, the Population, and the Environment |
Q33419863 | Epidemiological analysis of a large enterohaemorrhagic Escherichia coli O111 outbreak in Japan associated with haemolytic uraemic syndrome and acute encephalopathy |
Q38847100 | Epidemiological and Microbiological Investigation of an Outbreak of Severe Disease from Shiga Toxin-Producing Escherichia coli O157 Infection Associated with Consumption of a Slaw Garnish |
Q40288170 | Epidemiology and outcome of acute kidney injury in children, a single center study. |
Q34134385 | Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000-2010 |
Q31010561 | Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network. |
Q26801344 | Escherichia coli O157 Outbreaks in the United States, 2003-2012 |
Q27329964 | Escherichia coli O157:H7 super-shedder and non-shedder feedlot steers harbour distinct fecal bacterial communities |
Q36089500 | Estimating the burden of foodborne diseases in Japan |
Q41522138 | Exploiting the power of OMICS approaches to produce E. coli O157 vaccines |
Q33414737 | Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis |
Q35199053 | Glycolipid binding preferences of Shiga toxin variants |
Q44843157 | Ground beef consumption patterns in the United States, FoodNet, 2006 through 2007. |
Q89373702 | Haemolytic uraemic syndrome |
Q33401184 | Haemolytic uraemic syndrome during shigellosis |
Q58798874 | Haemolytic uremic syndrome surveillance in children less than 15 years in Belgium, 2009-2015 |
Q91810472 | Hemolytic Uremic Syndrome With Severe Neurologic Complications in an Adult |
Q30249618 | Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature |
Q34630438 | In vitro colonization of the muscle extracellular matrix components by Escherichia coli O157:H7: the influence of growth medium, temperature and pH on initial adhesion and induction of biofilm formation by collagens I and III. |
Q38234198 | Infectious diarrhea: an overview |
Q33419051 | Investigation of an outbreak of bloody diarrhea complicated with hemolytic uremic syndrome |
Q36628246 | Isothiocyanates as effective agents against enterohemorrhagic Escherichia coli: insight to the mode of action |
Q48352239 | Management of Shiga toxin producing Escherichia coli-infected children: A multi-national, multi-specialty survey |
Q33427581 | Mapping of genetic loci that modulate differential colonization by Escherichia coli O157:H7 TUV86-2 in advanced recombinant inbred BXD mice |
Q41251555 | Molecular Subtyping of Shiga Toxin-Producing Escherichia coli Using a Commercial Repetitive Sequence-Based PCR Assay |
Q39781160 | Molecular characterization of diarrheagenic Escherichia coli strains from stools samples and food products in Colombia |
Q35331334 | Molecular profiling of Escherichia coli O157:H7 and non-O157 strains isolated from humans and cattle in Alberta, Canada |
Q40323901 | Multistate Outbreak of Escherichia coli O157:H7 Infections Associated with Consumption of Fresh Spinach: United States, 2006. |
Q40143190 | Nationwide prevalence and risk factors for faecal carriage of Escherichia coli O157 and O26 in very young calves and adult cattle at slaughter in New Zealand. |
Q33933481 | Neuropsychological outcome after complicated Shiga toxin-producing Escherichia coli infection |
Q33965188 | Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7. |
Q38401990 | Outbreak of Escherichia coli O104:H4 infections associated with sprout consumption - Europe and North America, May-July 2011. |
Q34149045 | Outbreaks of virulent diarrheagenic Escherichia coli--are we in control? |
Q44712430 | Postdiarrheal hemolytic uremic syndrome in persons aged 65 and older in foodnet sites, 2000-2006. |
Q36970605 | Prevalence and relatedness of Escherichia coli O157:H7 strains in the feces and on the hides and carcasses of U.S. meat goats at slaughter |
Q39122055 | Protection against Shiga Toxins |
Q92998227 | QseC Signaling in the Outbreak O104:H4 Escherichia coli Strain Combines Multiple Factors during Infection |
Q33400310 | Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis |
Q64992859 | Roles of Shiga Toxins in Immunopathology. |
Q40481458 | School outbreak of Escherichia coli O157 with high levels of transmission, Staffordshire, England, February 2012. |
Q92882569 | Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review |
Q26752966 | Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic Applications |
Q35003696 | Shiga toxin 2-induced endoplasmic reticulum stress is minimized by activated protein C but does not correlate with lethal kidney injury. |
Q30360953 | Shiga toxin 2a and Enteroaggregative Escherichia coli--a deadly combination |
Q33402959 | Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies |
Q30411012 | Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence |
Q33411533 | Shiga toxin-producing Escherichia coli O157 is more likely to lead to hospitalization and death than non-O157 serogroups--except O104 |
Q34741273 | Shiga toxin-producing Escherichia coli in children: diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection |
Q34298167 | Shiga toxin-producing Escherichia coli: a single-center, 11-year pediatric experience. |
Q85101358 | Shiga toxin-producingEscherichia coliO157 associated with human infections in Switzerland, 2000–2009 |
Q33404640 | Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals |
Q92465398 | Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study |
Q33401142 | Strategies for surveillance of pediatric hemolytic uremic syndrome: Foodborne Diseases Active Surveillance Network (FoodNet), 2000-2007. |
Q91782054 | Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition |
Q100559126 | Systematic analysis of infectious disease outcomes by age shows lowest severity in school-age children |
Q92683941 | The Escherichia coli O157:H7 carbon starvation-inducible lipoprotein Slp contributes to initial adherence in vitro via the human polymeric immunoglobulin receptor |
Q54202078 | The effect of transportation and lairage on faecal shedding and carcass contamination with Escherichia coli O157 and O26 in very young calves in New Zealand. |
Q33400961 | The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak |
Q35173590 | The occurrence and prevention of foodborne disease in vulnerable people. |
Q58690782 | Thrombotic microangiopathies |
Q47273691 | Validation of Whole Genome Sequencing for Identification and Characterisation of Shiga Toxin-Producing Escherichia coli to produce standardised data to enable data sharing |
Q33728306 | When a healthy diet turns deadly |
Q57150317 | [A Slightly Different Gastroenteritis] |
Search more.